AZIZ, M. Which of the direct acting anti-viral agents is the better drug in terms of efficacy, cost and safety, Boceprevir or Telaprevir?. Medical Science and Discovery, [S. l.], v. 6, n. 5, p. 88–95, 2019. Disponível em: https://medscidiscovery.com/index.php/msd/article/view/233. Acesso em: 16 apr. 2024.